Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

被引：0
|
作者：
Nakagawa, Hidemi [1 ]
Nemoto, Osamu [2 ]
Igarashi, Atsuyuki [3 ]
Saeki, Hidehisa
Kabashima, Kenji [4 ,5 ]
Oda, Manabu [6 ]
Nagata, Takeshi [6 ]
机构：
[1] Jikei Univ, Sch Med, Tokyo, Japan
[2] Kojinkai Sapporo Skin Clin, Tokyo, Japan
[3] NTT Med Ctr Tokyo, Dept Dermatol, Tokyo, Japan
[4] Nippon Med Sch, Dept Dermatol, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Dermatol, Tokyo, Japan
[6] Japan Tobacco Inc, Pharmaceut Div, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
25094
引用
收藏
页码：AB52 / AB52
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of topical delgocitinib (JTE-052), janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase III, randomized, double-blind, vehicle-controlled study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kaino, Hironobu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB199 - AB199
  • [32] LONG-TERM EFFICACY AND TOLERABILITY OF GOLIMUMAB IN ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS OF THE OPEN-LABEL EXTENSION OF A RANDOMIZED, DOUBLE-BLIND STUDY
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W. P.
    Braun, J.
    Bergman, G.
    Curtis, S. P.
    Tzontcheva, A.
    Philip, G.
    Huyck, S.
    Sieper, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 752 - 752
  • [33] Clindamycin/benzoyl peroxide in the treatment of perioral dermatitis: A double-blind, randomized, vehicle-controlled study
    Draelos, Z
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB85 - AB85
  • [34] Topically applied tacrolimus ointment in pediatric atopic dermatitis patients: Results of a large open-label study
    Schneider, L
    Roberts, R
    Berger, W
    Prenner, BM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S160 - S160
  • [35] Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study
    Kuwana, Masataka
    Ito, Tomoki
    Kowata, Shugo
    Hatta, Yoshihiro
    Fujimaki, Katsumichi
    Naito, Kensuke
    Kurahashi, Shingo
    Kagoo, Toshiya
    Tanimoto, Kazuki
    Saotome, So
    Tomiyama, Yoshiaki
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (02) : E55 - E59
  • [36] Long-Term Tolerability and Efficacy of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results from the Open-Label Extension of a Randomized, Double-Blind Study
    van der Heijde, Desiree
    Dougados, Maxime
    Maksymowych, Walter
    Bergman, Gina
    Curtis, Sean P.
    Tzontcheva, Anjela
    Philip, George
    Huyck, Susan
    Sieper, Joachim
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [37] Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 PlaceboControlled, Double-Blind, Parallel-Group Study
    Kuwana, Masataka
    Ito, Tomoki
    Kowata, Shugo
    Hatta, Yoshihiro
    Fujimaki, Katsumichi
    Naito, Kensuke
    Kurahashi, Shingo
    Kagoo, Toshiya
    Tanimoto, Kazuki
    Shichiri, Natsuko
    Saotome, So
    Masuda, Esteban
    Tomiyama, Yoshiaki
    BLOOD, 2023, 142
  • [38] Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: Results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial
    Guerrini, Renzo
    Rosati, Anna
    Bradshaw, Kate
    Giorgi, Luigi
    EPILEPSIA, 2014, 55 (04) : 568 - 578
  • [39] Efficacy and safety results of a randomized, double-blind, vehicle-controlled phase 2 study of roflumilast foam 0.3% in patients with seborrheic dermatitis
    Zirwas, M.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 13 - 13
  • [40] Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study
    Takashi Wada
    Masaya Inagaki
    Toru Yoshinari
    Ryuji Terata
    Naoko Totsuka
    Miki Gotou
    Gaia Hashimoto
    Clinical and Experimental Nephrology, 2021, 25 : 120 - 130
12345